Products billed under this code include Riastap.
The billing unit for this code changed over time, so payment limits from different quarters may not be directly comparable. Check the billing unit column below.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Riastap | CSL Behring L.L.C. | 63833-0891-51 | 1 | $1.428 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.428 | −$0.06 | 1 MG | Inj human fibrinogen con nos | v1, posted September 17, 2026 |
| 3Q26 | $1.488 | −$0.036 | 1 MG | Inj human fibrinogen con nos | v1, posted September 15, 2026 |
| 2Q26 | $1.524 | −$0.001 | 1 MG | Inj human fibrinogen con nos | v1, posted September 15, 2026 |
| 1Q26 | $1.525 | +$0.006 | 1 MG | Inj human fibrinogen con nos | v1, posted September 15, 2026 |
| 4Q25 | $1.519 | $0.00 | 1 MG | Inj human fibrinogen con nos | v1, posted September 8, 2026 |
| 3Q25 | $1.519 | +$0.035 | 1 MG | Inj human fibrinogen con nos | v1, posted March 10, 2026 |
| 2Q25 | $1.484 | +$0.001 | 1 MG | Inj human fibrinogen con nos | v1, posted March 10, 2026 |
| 1Q25 | $1.483 | +$0.037 | 1 MG | Inj human fibrinogen con nos | v1, posted December 19, 2025 |
| 4Q24 | $1.446 | – | 1 MG | Inj human fibrinogen con nos | v1, posted June 11, 2025 |
| 3Q24 | $1.444 | −$0.001 | 1 IU | Inj human fibrinogen con nos | v1, posted June 11, 2025 |
| 2Q24 | $1.445 | +$0.063 | 1 IU | Inj human fibrinogen con nos | v1, posted March 11, 2025 |
| 1Q24 | $1.382 | +$0.001 | 1 IU | Inj human fibrinogen con nos | v1, posted December 19, 2024 |
| 4Q23 | $1.381 | −$0.002 | 1 IU | Inj human fibrinogen con nos | v1, posted October 10, 2024 |
| 3Q23 | $1.383 | $0.00 | 1 IU | Inj human fibrinogen con nos | v1, posted June 5, 2024 |
| 2Q23 | $1.383 | +$0.031 | 1 IU | Inj human fibrinogen con nos | v1, posted February 23, 2024 |
| 1Q23 | $1.352 | +$0.01 | 1 IU | Inj human fibrinogen con nos | v1, posted December 6, 2023 |
| 4Q22 | $1.342 | +$0.001 | 1 IU | Inj human fibrinogen con nos | v1, posted June 22, 2023 |
| 3Q22 | $1.341 | $0.00 | 1 IU | Inj human fibrinogen con nos | v1, posted June 9, 2023 |
| 2Q22 | $1.341 | +$0.043 | 1 IU | Inj human fibrinogen con nos | v1, posted December 14, 2022 |
| 1Q22 | $1.298 | +$0.001 | 1 IU | Inj human fibrinogen con nos | v1, posted June 8, 2022 |
| 4Q21 | $1.297 | $0.00 | 1 IU | Inj human fibrinogen con nos | v1, posted June 2, 2022 |
| 3Q21 | $1.297 | −$0.001 | 1 IU | Inj human fibrinogen con nos | v1, posted June 2, 2022 |
| 2Q21 | $1.298 | +$0.041 | 1 IU | Inj human fibrinogen con nos | v1, posted March 1, 2022 |
| 1Q21 | $1.257 | – | 1 IU | Inj human fibrinogen con nos | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
